FROM THE FOUNDATION

Money in the Bank

The Medi-Cal EHR incentive program could provide up to $2 billion in federal incentives to eligible California providers and result in more state revenues and thousands of jobs.

The Good and Bad of High-Deductible Health Plans

Health Affairs looks at the pros and cons of consumers paying more of their medical costs. As HDHPs grow in popularity, billions of dollars may be saved, but prevention might decline.

Career Opportunity: Senior Program Officer

This position will play a major role in furthering the goals and objectives of the foundation's Better Chronic Disease Care program.

Chronic Disease Care

Thursday, February 09, 2012

FDA Grants Priority Review to Genetech Breast Cancer Drug

On Tuesday, San Francisco-based Genentech announced that FDA will give its experimental breast cancer treatment pertuzumab a priority review. Genetech, a unit of Roche, said the agency will make a decision about the drug by June 8.



Readers are invited to send feedback to: chl@chcf.org